| #199 |
Timothy Chan |
Biogen Ma |
1 |
| #199 |
Yu-Hua Tseng |
Joslin Diabetes Center |
1 |
| #199 |
John Reynders |
Oracle |
1 |
| #199 |
David Arzumanyan |
Unknown |
1 |
| #199 |
Csanad M. Varga |
Millennium Pharmaceuticals |
1 |
| #199 |
John Stark |
Bio-Rad Laboratories |
1 |
| #199 |
Pawel Jurczyk |
Google |
1 |
| #199 |
Phillip A. Sharp |
MIT |
1 |
| #199 |
Selim Nahas |
Applied Materials |
1 |
| #199 |
Daphne Psacharopoulos |
Cvs Pharmacy |
1 |
| #199 |
Dor Aharony |
Dell Products |
1 |
| #199 |
James S. Pringle |
Draper Laboratory |
1 |
| #199 |
John Edgar MacLean |
Lumiradx Uk |
1 |
| #199 |
Lloyd B. Klickstein |
Brigham and Women's Hospital |
1 |
| #199 |
Hsiao-Ming Lu |
The General Hospital |
1 |
| #199 |
Jahir Pabon |
Schlumberger Technology |
1 |
| #199 |
Soleh Udin Al Ayubi |
— |
1 |
| #199 |
Mark Florence |
American Messaging Services |
1 |
| #199 |
Kevin M. Connolly |
Intel |
1 |
| #199 |
Oleg Shilovitsky |
— |
1 |
| #199 |
Carmen Bozic |
Biogen Ma |
1 |
| #199 |
Paula S. Hochman |
Biogen Idec Ma |
1 |
| #199 |
Louis Grenier |
Infinity Pharmaceuticals |
1 |
| #199 |
Dennis Moreau |
Emc |
1 |
| #199 |
Arthur C. Ley |
Dyax |
1 |
| #199 |
Boshan Mo |
— |
1 |
| #199 |
Roman Muzykin |
Oracle |
1 |
| #199 |
Guiqing Huang |
— |
1 |
| #199 |
Edward J. Olhava |
Epizyme |
1 |
| #199 |
Nicholas Dronen |
Here Global B.V. |
1 |
| #199 |
Matthew C. Ebbs |
Rai Strategic Holdings |
1 |
| #199 |
Natasha Mariam Kablaoui |
Pfizer |
1 |
| #199 |
Andrew Spann |
Meta |
1 |
| #199 |
David L. Sloman |
Merck |
1 |
| #199 |
Kenneth BREUER |
Brown University |
1 |
| #199 |
Xiaoyang Zheng |
Genzyme |
1 |
| #199 |
Mordechai Rothschild |
MIT |
1 |
| #199 |
Nick Reynolds |
— |
1 |
| #199 |
Daniel Sazer |
MIT |
1 |
| #199 |
Olga Tomashevskaya |
Boston Foundation For Sight |
1 |
| #199 |
Caroline Attaro Genco |
Trustees Of Tufts College |
1 |
| #199 |
Kevin Brousseau |
Bose |
1 |
| #199 |
Jon Madison |
MIT |
1 |
| #199 |
Ron Sostek |
Harvard Apparatus Regenerative Technology |
1 |
| #199 |
Andrew Chen |
Broadcom |
1 |
| #199 |
John V. W. Reynders |
Alexion Pharmaceuticals |
1 |
| #199 |
Joseph A. Jarrell |
Waters Technologies |
1 |
| #199 |
Carl Novina |
Dana-Farber Cancer Institute |
1 |
| #199 |
Amanda Elizabeth HANSON |
Jounce Therapeutics |
1 |
| #199 |
Kenneth P. Weiss |
Comcast |
1 |